Abstract
OBJECTIVE: Leptin regulates energy production rates and body weight, which are frequently altered in hyperthyroidism. Data on a possible interaction between leptin and thyroid hormones are controversial. We assessed leptin serum concentrations, BMI, proportional fat tissue mass and thyroid hormones in hyperthyroid patients in a long-term follow-up after radioiodine therapy.
DESIGN: The study included 28 hyperthyroid patients (mean age 66 y) before and up to one y after radioiodine therapy. Leptin and thyroid hormones, general parameters, BMI, proportional fat tissue (PFT) measurements by DEXA and thyroid morphology were recorded. Twenty-four age-matched euthyroid individuals (mean age 63 y) served as controls.
RESULTS: At baseline, leptin concentrations were significantly decreased in all hyperthyroid patients as compared to controls. One year after radioiodine therapy, 71% of the patients were euthyroid (group A) and 29% remained hyperthyroid (group B). BMI and PFT increased in both groups. While leptin concentrations remained low in group B, they normalised in group A after 6 to 12 months. Changes in leptin and thyroid hormone concentrations were positively correlated in group A patients (r=0.49, P=0.03) but not in patients remaining hyperthyroid.
CONCLUSION: Our data indicate a dissociation in the regulation of plasma leptin and BMI as well as proportional fat tissue in hyperthyroid patients which may be attributable to differences in lean and adipose mass weight gain after radioiodine therapy or direct influences of thyroid hormones on leptin regulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hamilton BS, Paglia D, Kwan AYM, Deitel M . Increased obese mRNA expression in omental fat cells from massively obese humans Nature Med 1995 1: 953–956.
Lönnqvist F, Arner P, Nordfors L, Schalling M . Overexpression of the obese (ob) gene on adipose tissue of human obese subjects Nature Med 1995 1: 950–953.
Pinkney JH, Goodrick SJ, Katz J, Johnson AB, Lightman SL, Coppack SW . Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects Clin Endocrinol Oxf 1998 49: 583–588.
Carantoni M, Abbasi F, Azhar S, Schaaf P, Reaven GM . Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance? J Clin Endocrinol Metab 1999 84: 869–872.
Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, Bue-Vallenskey J, Stephens TW . Regulation of expression of ob-mRNA and protein by glucocorticoids and cAMP J Biol Chem 1996 271: 5301–5304.
Moinat M, Deng C, Muzzin P, Assimacopoulos-Jeannet F, Seydoux J, Dulloa AG, Giacobino JP . Modulation of obese gene expression in rat brown and white adipose tissue FEBS Lett 1995 373: 131–134.
Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR . Endotoxin and cytokines induce expression of leptin, the ob gene product in hamsters J Clin Invest 1996 97: 2152–2157.
Rosenbaum M, Nicolson M, Hirsch J . Effects of gender, body composition, and menopause on plasma concentrations of leptin J Clin Endocrinol Metab 1996 81: 3424–3427.
Escobar-Morreale HF, Escobar del Rey F, Morreale de Escobar G . Thyroid hormones influence serum leptin concentrations in the rat Endocrinology 1997 138: 4485–4488.
Diekman MJM, Romijn JA, Endert E, Sauerwein H, Wiersinga WM . Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and hypothyroid women Thyroid 1998 8: 1081–1086.
Ozata M, Ozisik G, Bingol N, Corakci A . The effects of thyroid status on plasma leptin levels in women J Endocrinol Invest 1998 21: 337–341.
Yoshida T, Momotani N, Hayashi M, Monkawa T, Ito K, Saruta T . Serum leptin concentrations in patients with thyroid disorders Clin Endocrinol Oxf 1998 48: 299–302.
Valcavi R, Zini M, Peino R, Casanueva FF, Dieguez C . Influence of thyroid status on serum immunoreactive leptin levels J Clin Endocrinol Metab 1997 82: 1632–1634.
Sesmilo G, Casamitjana R, Haperin I, Gomis R, Vildardell E . Role of thyroid hormones on serum leptin levels Eur J Endocrinol 1998 139: 428–430.
Sreenan S, Caro JF, Refetoff S . Thyroid dysfunction is not associated with alterations in serum leptin levels Thyroid 1997 7: 407–409.
Widjaja A, Lill C, Radamm C, Ötting G, von zur Mühlen A, Brabant G . Serum leptin levels are not altered in thyroid dysfunction in humans. In: Blum WF, Kiess W, Rascher W (eds) Leptin—the Voice of the Adipose Tissue, J. A. Barth Verlag Edition J & J: Heidelberg, Leipzig, Germany 1997 pp 264–268.
Corbetta S, Englaro P, Giambona S, Persani L, Blum WF, Beck-Peccoz P . Lack of effects of circulating thyroid hormone levels on serum leptin concentrations Eur J Endocrinol 1997 137: 659–663.
Leonhardt U, Ritzel U, Schäfer G, Becker W, Ramadori G . Serum leptin levels in hypo- and hyperthyroidism J Endocrinol 1998 157: 75–79.
Yoshida T, Monkawa T, Hayashi M, Saruta T . Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3-L1 adipocytes Biochem Biophys Res Commun 1997 232: 822–826.
Leonhard U, Gerdes E, Ritzel U, Schafer G, Becker W, Ramadori G . Immunoreactive leptin and leptin mRNA expression are increased in rat hypo- but not hyperthyroidism J Endocrinol 1999 163: 115–121.
Mantzoros CS, Rosen HN, Greenspan SL, Flier JS, Moses AC . Short-term hyperthyroidism has no effect on leptin levels in man J Clin Endocrinol Metab 1997 82: 497–499.
Kautzky-Willer A, Ludwig C, Nowotny P, Roden A, Huemer C, Widhalm K, Vierhapper H, Waldhausl W, Roden M . Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment Eur J Clin Invest 1999 29: 395–403.
Zimmermann-Belsing T, Dreyer M, Holst JJ, Feldt-Rasmussen U . The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects Clin Endocrinol Oxf 1998 49: 589–595.
Larsen PR, Davies TF, Hay ID . The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds) Textbook of Endocrinology. Saunders: Philadelphia 1998 pp 389–515.
Haarbo J, Gotfredsen A, Hassager C, Christiansen C . Validation of body composition by dual energy X-ray absorptiometry (DEXA) Clinical Physiology 1991 11: 331–334.
De la Rosa RE, Hennessey JV, Tucci JR . A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis Thyroid 1997 7: 401–404.
Jansson S, Berg G, Lindstedt G, Michanek A, Nystrom E . Overweight—a common problem among women treated for hyperthyroidism Postgrad Med J 1993 69: 107–111.
Considine RV, Sinha MK, Heiman ML, Kriaucimras A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF . Serum immuno-reactive leptin concentrations in normal-weight and obese humans New Engl J Med 1996 334: 292–295.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Obermayer-Pietsch, B., Frühauf, G., Lipp, R. et al. Dissociation of leptin and body weight in hyperthyroid patients after radioiodine treatment. Int J Obes 25, 115–120 (2001). https://doi.org/10.1038/sj.ijo.0801479
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0801479